Ha Do is currently a Principal Scientist of API Development at Alcon, specializing in synthetic chemistry. They completed a Ph.D. in Organic Chemistry at the University of Houston in 2015 and have significant research experience in designing and synthesizing inhibitors for various therapeutic targets. Previous roles include postdoctoral positions at the University of Minnesota and Northwestern University, focusing on HIV and neurodegenerative diseases, respectively. From 2011 to 2015, they served as a Graduate Research Assistant at the University of Houston, where they worked on novel therapeutic designs. Additionally, Ha held a senior scientist position at Reata Pharmaceuticals, Inc. prior to its acquisition by Biogen.
This person is not in the org chart
This person is not in any teams
This person is not in any offices